Concourse Financial Group Securities’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8209 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8419 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8421 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8433 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8436 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8368 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8164 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7955 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7666 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7673 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7495 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7394 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7254 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7138 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6908 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6661 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6431 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6234 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6023 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5864 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5796 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5708 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5546 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5588 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5492 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5398 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5224 |
|